Regulation of local tissue-type plasminogen activator release by endothelium-dependent and endothelium-independent agonists in human vasculature

This publication has 32 references indexed in Scilit:

• Abnormally high circulation levels of tissue plasminogen activator and plasminogen activator inhibitor-1 in patients with a history of ischemic stroke.
  Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1994
• Predictive value of tissue plasminogen activator mass concentration on long-term mortality in patients with coronary artery disease. A 7-year follow-up.
  Circulation, 1993
• Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park Heart Study
  The Lancet, 1993
• Endogenous tissue-type plasminogen activator and risk of myocardial infarction
  The Lancet, 1993
• Endothelium-dependent vasodilation is attenuated in patients with heart failure.
  Circulation, 1991
• Abnormal Endothelium-Dependent Vascular Relaxation in Patients with Essential Hypertension
  New England Journal of Medicine, 1990
• Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans.
  Journal of Clinical Investigation, 1990
• Indirect evidence for release of endothelium-derived relaxing factor in human forearm circulation in vivo. Blunted response in essential hypertension.
  Circulation, 1990
• PLASMINOGEN ACTIVATOR INHIBITOR IN PLASMA: RISK FACTOR FOR RECURRENT MYOCARDIAL INFARCTION
  The Lancet, 1987
• Release of plasminogen activator by acetylcholine from the isolated perfused pig ear
  Thrombosis Research, 1979